Safinamide Mesylate

Overview

Safinamide Mesylate is a selective monoamine oxidase B (MAO-B) inhibitor with both dopaminergic and non-dopaminergic properties. It is primarily used in the treatment of Parkinson's disease as an add-on therapy to levodopa/carbidopa.

API suppliers (1)

Suppliers of Safinamide Mesylate backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• SOLARA ACTIVE PHARMA SCIENCES LTD1 active DMF

Therapeutic areas